A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT00955721 · TERMINATED
Trial details
- NCT number
- NCT00955721
- Sponsor
- University of Miami
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2014-07-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.